Rhumatologie

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial

Rheumatology (Oxford) 2009;48:1429–34. Martin Soubrier, Xavier Pue´chal, Jean Sibilia, Xavier Mariette, Olivier Meyer, Bernarde Combe, Rene Marc Flipo, Denis Mulleman, Francis Berenbaum, Charles Zarnitsky, Thierry Schaeverbeke, Patrice Fardellone and Maxime Dougados

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Methotrexate Maintenance After Initiation of Biological or Targeted Synthetic DMARDs  in Rheumatoid Arthritis: Results from the 2‑Year  Longitudinal Prospective Non‑interventional  STRATEGE2 Study
Actualités RCTS - Publications - Rhumatologie - Facultatif

Methotrexate Maintenance After Initiation of Biological or Targeted Synthetic DMARDs in Rheumatoid Arthritis: Results from the 2‑Year Longitudinal Prospective Non‑interventional STRATEGE2 Study

methotrexate maintenance RA
Actualités RCTS - Publications - Rhumatologie - Facultatif

Methotrexate Maintenance RA: STRATEGE2 2‑Year Study

Publication Bias in Drug Safety: RCTs Study on Bisphosphonates
Publications - Success stories - Rhumatologie - Facultatif

Publication Bias in Drug Safety: RCTs Study on Bisphosphonates